It's not often that you see a 1,000 person drug trial for fibromyalgia or any other disease but one recently begun in the U.S. and Canada. A Japanese drug company, Daiichi Sankyo, is making a huge bet on a new drug called mirogabalin for fibromyalgia and other diseases.
If mirogabalin sounds Read more [...]
A Neuroinflammation Story
Who knows how it started? Did those two mysterious red dots on a vein on her arm mean anything? Could that businessman who sneezed on her in the subway triggered her illness? Or did her biological stars just suddenly align in the strangest configuration ever?
Nobody Read more [...]
Clearly, issues concerning reliability of clinical diagnosis are complex and have important research and practical implications. Jason et. al
In the beginning of his overview on the IOM definition and name change Jason notes the numerous false starts and botched definitions that have plagued chronic Read more [...]
(This blog is taken from three sources. A radio interview with Jarred Younger, information on the University of Alabama at Birmingham website and an interview I did with him. Thanks to Jarred for his time.)
Unlike others, Younger was never phased by the lack of attention given fibromyalgia and chronic Read more [...]
There has been a growing consensus that whatever chronic Lyme disease is it's not due to the bacteria. This concensus has been based on studies indicating that short term antibiotic treatment following an infection, causes a dramatic reduction in antibodies. That drop in antibody levels is believed Read more [...]
Thousands of small alterations in our genes exist. This propensity for genetic experimentation has helped the human race adapt and thrive. Many never have an impact. Others may be helpful in some situations and problematic in other situations, and some, often in combination with other gene variations Read more [...]
“My goal is to help those suffering from chronic conditions better understand the intersection between our neurobiology, immunology and the deepest inner workings of the human heart — and to use that understanding to embark on a transformation to healing.” —Donna Jackson Nakazawa
Donna Jackson Read more [...]
Dr's Fluge and Mella had produced a breakthrough and they had a new problem. Over 60% of the ME/CFS patients they gave the powerful immune drug Rituximab significantly improved but they tended to relapse when they were off the drug. Plus some patients didn't react to the drug.
In this study Read more [...]